Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC—A Brief Report

作者：Gregory J. Riely, Myung‐Ju Ahn, Jeffrey M. Clarke, Ibiayi Dagogo‐Jack, Raymond M. Esper, Enriqueta Felip, Francesco Gelsomino, Jonathan W. Goldman, Maen Hussein, Melissa L. Johnson, Kristen A. Marrone, Daniel Morgensztern, Ernest Nadal, Marcelo V. Negrão, Michael Offin, Mariano Provencio, Suresh S. Ramalingam, Logan Roof, Rachel E. Sanborn, Egbert F. Smit, Anne S. Tsao, Tiziana Usari, Ann Alcasid, Keith D. Wilner, Svitlana Tonkovyd, Xiaosong Zhang, Bruce E. Johnson · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2025.05.023 · 被引用次数：12 · 研究领域：Melanoma and MAPK Pathways、Lung Cancer Treatments and Mutations、Colorectal Cancer Treatments and Studies